| Lastest Insider Transactions Of Intellia Therapeutics, Inc. ( NTLA ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | 2026-08-20 | Sell | 22,675 | 12.65 | 286,819 | 2026-08-24 16:05:04 |
| NTLA | Intellia Therapeutics, Inc. | Dulac Edward J III | EVP, Chief Financial Officer | 2026-07-22 | Sell | 8,111 | 11.25 | 91,249 | 2026-07-24 17:26:12 |
| NTLA | Intellia Therapeutics, Inc. | Dube Michael P | VP, Chief Accounting Officer | 2026-07-01 | Sell | 2,641 | 16.78 | 44,316 | 2026-07-06 17:02:06 |
| NTLA | Intellia Therapeutics, Inc. | Dulac Edward J III | EVP, Chief Financial Officer | 2026-07-02 | Sell | 4,677 | 18.00 | 84,186 | 2026-07-06 17:01:06 |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | 2026-01-05 | Sell | 34,146 | 9.21 | 314,485 | 2026-01-07 16:05:54 |
| NTLA | Intellia Therapeutics, Inc. | Schultes Birgit C | EVP, Chief Scientific Officer | 2026-01-05 | Sell | 8,508 | 9.21 | 78,359 | 2026-01-07 16:05:16 |
| NTLA | Intellia Therapeutics, Inc. | BASTA JAMES | EVP, General Counsel | 2026-01-05 | Sell | 10,397 | 9.21 | 95,756 | 2026-01-07 16:05:11 |
| NTLA | Intellia Therapeutics, Inc. | Cohen Fred E | Directior | 2026-01-05 | Buy | 150,000 | 9.35 | 1,402,500 | 2026-01-07 16:05:06 |
| NTLA | Intellia Therapeutics, Inc. | Lebwohl David | EVP, Chief Medical Officer | 2026-01-05 | Sell | 11,903 | 9.21 | 109,627 | 2026-01-07 16:04:38 |
| NTLA | Intellia Therapeutics, Inc. | Clark Eliana | EVP, Chief Technical Officer | 2026-01-05 | Sell | 9,515 | 9.21 | 87,633 | 2026-01-07 16:03:52 |
| NTLA | Intellia Therapeutics, Inc. | Dulac Edward J III | EVP, Chief Financial Officer | 2026-01-05 | Sell | 6,379 | 9.21 | 58,751 | 2026-01-07 16:02:56 |
| NTLA | Intellia Therapeutics, Inc. | Dube Michael P | VP, Chief Accounting Officer | 2026-01-05 | Sell | 2,989 | 9.21 | 27,529 | 2026-01-07 16:01:51 |
| NTLA | Intellia Therapeutics, Inc. | Dube Michael P | VP, Chief Accounting Officer | 2026-01-05 | Sell | 2,989 | 9.21 | 27,529 | 2026-01-07 16:01:51 |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | 2025-12-11 | Sell | 88,146 | 9.49 | 836,384 | 2025-12-12 16:09:29 |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | 2025-12-11 | Option Exercise | 58,516 | 6.83 | 399,664 | 2025-12-12 16:09:29 |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | 2025-12-11 | Sell | 88,146 | 9.49 | 836,384 | 2025-12-12 16:09:29 |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | 2025-12-11 | Option Exercise | 58,516 | 6.83 | 399,664 | 2025-12-12 16:09:29 |
| NTLA | Intellia Therapeutics, Inc. | Schultes Birgit C | EVP, Chief Scientific Officer | 2025-10-01 | Sell | 31 | 17.38 | 539 | 2025-10-03 17:13:56 |
| NTLA | Intellia Therapeutics, Inc. | Dube Michael P | VP, Chief Accounting Officer | 2025-10-01 | Sell | 1,871 | 17.38 | 32,518 | 2025-10-03 17:13:00 |
| NTLA | Intellia Therapeutics, Inc. | CHASE WILLIAM J | Directior | 2025-08-20 | Buy | 100,000 | 10.03 | 1,003,000 | 2025-08-22 16:30:14 |
| NTLA | Intellia Therapeutics, Inc. | Dulac Edward J III | EVP, Chief Financial Officer | 2025-07-23 | Sell | 7,462 | 14.02 | 104,617 | 2025-07-25 16:05:06 |
| NTLA | Intellia Therapeutics, Inc. | Clark Eliana | EVP, Chief Technical Officer | 2025-07-01 | Sell | 1,022 | 9.82 | 10,036 | 2025-07-03 16:11:49 |
| NTLA | Intellia Therapeutics, Inc. | Dube Michael P | VP, Chief Accounting Officer | 2025-07-02 | Sell | 2,503 | 9.95 | 24,905 | 2025-07-03 16:07:21 |
| NTLA | Intellia Therapeutics, Inc. | GOODMAN JESSE | Directior | 2025-06-30 | Sell | 3,094 | 9.39 | 29,068 | 2025-07-02 17:50:11 |
| NTLA | Intellia Therapeutics, Inc. | Bhanji Muna | Directior | 2025-04-29 | Sell | 265 | 8.50 | 2,253 | 2025-05-01 16:24:22 |
| NTLA | Intellia Therapeutics, Inc. | Clark Eliana | EVP, Chief Technical Officer | 2025-03-01 | Sell | 679 | 8.99 | 6,104 | 2025-03-04 16:43:16 |
| NTLA | Intellia Therapeutics, Inc. | Bhanji Muna | Directior | 2025-01-29 | Sell | 265 | 9.97 | 2,642 | 2025-01-31 16:17:16 |
| NTLA | Intellia Therapeutics, Inc. | Dube Michael P | VP, Chief Accounting Officer | 2025-01-03 | Sell | 1,372 | 12.18 | 16,711 | 2025-01-07 17:23:13 |
| NTLA | Intellia Therapeutics, Inc. | BASTA JAMES | EVP, General Counsel | 2025-01-03 | Sell | 7,074 | 12.18 | 86,161 | 2025-01-07 17:22:20 |
| NTLA | Intellia Therapeutics, Inc. | Lebwohl David | EVP, Chief Medical Officer | 2025-01-03 | Sell | 9,557 | 12.18 | 116,404 | 2025-01-07 17:20:25 |
| NTLA | Intellia Therapeutics, Inc. | Hicks Derek | EVP, Chief Business Officer | 2025-01-03 | Sell | 6,502 | 12.18 | 79,194 | 2025-01-07 17:20:23 |
| NTLA | Intellia Therapeutics, Inc. | Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | 2025-01-03 | Sell | 8,966 | 12.18 | 109,206 | 2025-01-07 17:16:22 |
| NTLA | Intellia Therapeutics, Inc. | Clark Eliana | EVP, Chief Technical Officer | 2025-01-02 | Sell | 7,978 | 12.17 | 97,089 | 2025-01-06 16:16:47 |
| NTLA | Intellia Therapeutics, Inc. | Dube Michael P | VP, Chief Accounting Officer | 2024-10-02 | Sell | 2,012 | 19.01 | 38,248 | 2024-10-04 17:29:43 |
| NTLA | Intellia Therapeutics, Inc. | Clark Eliana | EVP, Chief Technical Officer | 2024-07-01 | Sell | 405 | 22.93 | 9,287 | 2024-07-03 13:15:04 |
| NTLA | Intellia Therapeutics, Inc. | Verwiel Frank | Directior | 2024-06-17 | Sell | 1,505 | 25.00 | 37,625 | 2024-06-20 17:00:43 |
| NTLA | Intellia Therapeutics, Inc. | Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | 2024-01-08 | Sell | 2,275 | 28.87 | 65,682 | 2024-01-10 16:15:19 |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | 2024-01-03 | Sell | 19,223 | 29.46 | 566,310 | 2024-01-05 16:51:05 |
| NTLA | Intellia Therapeutics, Inc. | Lebwohl David | EVP, Chief Medical Officer | 2024-01-03 | Sell | 5,843 | 29.46 | 172,135 | 2024-01-05 16:50:36 |
| NTLA | Intellia Therapeutics, Inc. | Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | 2024-01-03 | Sell | 5,532 | 29.46 | 162,973 | 2024-01-05 16:50:26 |
| NTLA | Intellia Therapeutics, Inc. | Goddard Glenn | EVP, Chief Financial Officer | 2024-01-03 | Sell | 5,365 | 29.46 | 158,053 | 2024-01-05 16:49:15 |
| NTLA | Intellia Therapeutics, Inc. | Hicks Derek | EVP, Chief Business Officer | 2024-01-03 | Sell | 3,877 | 29.46 | 114,216 | 2024-01-05 16:46:39 |
| NTLA | Intellia Therapeutics, Inc. | BASTA JAMES | EVP, General Counsel | 2024-01-03 | Sell | 3,805 | 29.46 | 112,095 | 2024-01-05 16:45:39 |
| NTLA | Intellia Therapeutics, Inc. | Clark Eliana | EVP, Chief Technical Officer | 2024-01-03 | Sell | 4,608 | 29.50 | 135,954 | 2024-01-05 16:44:43 |
| NTLA | Intellia Therapeutics, Inc. | Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | 2024-01-01 | Option Exercise | 3,500 | 0.00 | 0 | 2024-01-03 17:35:50 |
| NTLA | Intellia Therapeutics, Inc. | Lebwohl David | EVP, Chief Medical Officer | 2024-01-01 | Option Exercise | 3,187 | 0.00 | 0 | 2024-01-03 17:34:10 |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | 2024-01-01 | Option Exercise | 7,848 | 0.00 | 0 | 2024-01-03 17:30:40 |
| NTLA | Intellia Therapeutics, Inc. | Goddard Glenn | EVP, Chief Financial Officer | 2024-01-01 | Option Exercise | 3,062 | 0.00 | 0 | 2024-01-03 17:28:42 |
| NTLA | Intellia Therapeutics, Inc. | Bhanji Muna | Directior | 2023-10-31 | Sell | 265 | 23.90 | 6,334 | 2023-11-02 16:42:59 |
| NTLA | Intellia Therapeutics, Inc. | Bhanji Muna | Directior | 2023-07-31 | Sell | 265 | 42.33 | 11,217 | 2023-08-02 17:19:39 |
| NTLA | Intellia Therapeutics, Inc. | Bhanji Muna | Directior | 2023-07-06 | Sell | 1,867 | 39.30 | 73,373 | 2023-07-10 17:21:43 |
| NTLA | Intellia Therapeutics, Inc. | Clark Eliana | EVP, Chief Technical Officer | 2023-07-03 | Sell | 360 | 40.51 | 14,584 | 2023-07-06 15:34:22 |
| NTLA | Intellia Therapeutics, Inc. | Clark Eliana | EVP, Chief Technical Officer | 2023-06-20 | Sell | 5,000 | 45.00 | 225,000 | 2023-06-22 17:52:19 |
| NTLA | Intellia Therapeutics, Inc. | Clark Eliana | EVP, Chief Technical Officer | 2023-06-20 | Option Exercise | 5,000 | 12.27 | 61,350 | 2023-06-22 17:52:19 |
| NTLA | Intellia Therapeutics, Inc. | BASTA JAMES | EVP, General Counsel | 2023-03-01 | Sell | 1,088 | 43.88 | 47,741 | 2023-03-03 17:10:35 |
| NTLA | Intellia Therapeutics, Inc. | Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | 2023-01-04 | Sell | 4,838 | 37.82 | 182,982 | 2023-01-06 17:39:56 |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | 2023-01-04 | Sell | 6,673 | 37.21 | 248,302 | 2023-01-06 17:32:49 |
| NTLA | Intellia Therapeutics, Inc. | Hicks Derek | EVP, Chief Business Officer | 2023-01-04 | Sell | 1,812 | 37.21 | 67,425 | 2023-01-06 17:29:43 |
| NTLA | Intellia Therapeutics, Inc. | Lebwohl David | EVP, Chief Medical Officer | 2023-01-04 | Sell | 2,574 | 37.21 | 95,779 | 2023-01-06 17:26:38 |
| NTLA | Intellia Therapeutics, Inc. | Goddard Glenn | EVP, Chief Financial Officer | 2023-01-04 | Sell | 2,427 | 37.21 | 90,309 | 2023-01-06 17:23:40 |
| NTLA | Intellia Therapeutics, Inc. | Clark Eliana | EVP, Chief Technical Officer | 2022-07-01 | Sell | 2,028 | 37.65 | 76,357 | 2023-01-06 17:21:01 |
| NTLA | Intellia Therapeutics, Inc. | BASTA JAMES | EVP, General Counsel | 2023-01-04 | Sell | 1,138 | 37.21 | 42,345 | 2023-01-06 17:19:11 |
| NTLA | Intellia Therapeutics, Inc. | Sepp-Lorenzino Laura | EVP, Chief Scientific Officer | 2023-01-01 | Option Exercise | 3,500 | 0.00 | 0 | 2023-01-04 20:38:29 |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | 2023-01-01 | Option Exercise | 7,848 | 0.00 | 0 | 2023-01-04 20:36:01 |
| NTLA | Intellia Therapeutics, Inc. | Lebwohl David | EVP, Chief Medical Officer | 2023-01-01 | Option Exercise | 3,187 | 0.00 | 0 | 2023-01-04 20:33:03 |
| NTLA | Intellia Therapeutics, Inc. | Goddard Glenn | EVP, Chief Financial Officer | 2023-01-01 | Option Exercise | 3,062 | 0.00 | 0 | 2023-01-04 20:29:37 |
